-
Mashup Score: 3Cannabis Use and Post-operative Complications in Patients Undergoing Pancreatic Resection - 2 year(s) ago
Many states have legalized medical cannabis with various reported therapeutic benefits. However, there is little data assessing the effects of cannabis on surgical outcomes. We sought to compare post-operative pancreatic resection complications between cannabis users and non-users.
Source: HPBCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Minimally invasive hepatopancreatic and biliary surgery in children: a large centre experience and review of the literature - 3 year(s) ago
Minimally invasive surgery (MIS) for hepatopancreatic and biliary (HPB) diseases has been widely used in adults, while in children, its application is limited due to its complexity. Herein, we report the experience of MIS for paediatric HPB diseases and literature review.
Source: HPBCategories: Healthcare Professionals, Latest HeadlinesTweet-
Minimally invasive hepatopancreatic and biliary surgery in children: a large centre experience and review of the literature #some4surgery https://t.co/z3DJ7Cbuvt
-
-
Mashup Score: 6
Radiofrequency ablation (RFA) is subject to “heat-sink” effects, particularly for treatment of tumors adjacent to major vessels.
Source: HPBCategories: Latest Headlines, Oncologists1Tweet-
RT @SStattner: Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence https://t.co/LwJz3Y5U5b 104 patients - 137…
-
-
Mashup Score: 13Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection - 4 year(s) ago
While resection is a recommended treatment for patients with stage 1 hepatocellular carcinoma (HCC), it remains controversial for multifocal disease. We sought to identify patients with multifocal HCC with survival after resection similar to patients with clinical stage 1 HCC.
Source: HPBCategories: Latest Headlines, Oncologists1Tweet-
For this weeks #AHPBA #JuniorSurgeonsCommittee - thoughts on resection for multifocal HCC? Criteria? @timnewhook19 @vreelant @OscarKSerrano @Nachomerlo @MiguelTobonL @ArvindSabesan @RSnyder_MD https://t.co/3YiuXNn4er
-
-
Mashup Score: 2
Neoadjuvant therapy (NT) is increasingly utilized for patients with pancreatic ductal adenocarcinoma (PDAC) but the nationwide incidence and long-term prognosis of a pathologic complete response (pCR) remains poorly understood.
Source: HPBCategories: Hem/OncsTweet-
From @jcloydmd @timpawlik & colleagues @OSUWexMed: Pathologic complete response (pCR) following neoadjuvant Rx in #PancreaticCancer is uncommon (~3% in National Cancer Database) but a highly significant predictor of median overall survival (77 months) https://t.co/5E3tarAR69 https://t.co/BRnAHbkVQT
-
RT @CamilleLStewart: 21% of our pancreatic surgery patients use cannabis - this deserves further study! https://t.co/WlH0D04BWQ